Skip to main
Jennifer Faith

Cannabis, Coffee, Clothing, Medical

All wrapped up into one holding-oh my!

A Look 👀 into Flora Growth $FLGC

Full Disclosure: I hold shares in Flora Growth $FLGC and believe this company is a hidden gem 💎 poised for expotential growth in the future. Just my opinion, not financial advice. I am not a financial advisor. All opinions are my own. Please do your own due diligence before making any investments.

Renewed optimism regarding US legalization of recreational use of Cannabis have made cannabis stocks pop on Friday. Think $HITI $CLVR $TLRY $SNDL $CGC Lawmakers plan to vote on the MORE Act within the House of Representatives this week. Yes we've been here before. An earlier version of the bill was passed in Dec 2020 but then fluttered out when it hit the Senate. Now, it's back. There are estimates that the legal cannabis market in America will hit $25 billion by 2025.

Personally, after this pandemic, I am ready for the roaring 20's that my grandparents enjoyed back in their day when the prohibition of alcohol was lifted. Only in our generation, it is cannabis.

Now, why am I so into $FLGC Flora Growth? The reasons go on and on!

It is a vertically integrated cannabis company focused on becoming the largest producer of low-cost naturally grown medicinal-grade #cannabis, cannabis oils, CBD-infused foods and beverages, and pharmaceutical grade medical and cosmetic grade derivatives from the cannabis plant🌿. Organic ingredients and value-chain sustainability across its portfolio to create products that help consumers restore and thrive.

Flora IPO was launched in May 2021. $FLGC

They grow cannabis 🌱 in one of the most biodiverse regions on our planet 🌎 - Bucaramanga, Colombia. They grow outdoors. On 100 Hectares (247.105 acres).

With steady 3 mph wind💨, 12 hour days, and a natural water source💧, ideal growing location for high-CBD and high-THC flower. My fellow gardeners🌿 on Public can tell you - to leverage the natural resources in this bio-diverse location...a gardeners dream 💚.

Their team includes expert scientists, biologists, and formulators.

They are committed to applied research 🔬 initiatives in all areas , including medical cannabis in order to become a leader in the discovery, development, manufacturing, and commercialization of novel, phytocannabinoid based OTC and prescription medicines and nutraceutical products to address a broad range of wellness concerns.

Their crops are used for wholesale ordering and extraction. They can craft products to customer needs.

But Flora didn't just tackle the medical cannabis sector. They have entered numerous markets, spanning 5 countries and growing daily.

Brands Under Flora Include:

🔹Tonino Lamborghini CBD Coffee! Coming very soon (early 2022) I ♥️ Coffee. I am invested in Starbucks $SBUX and Black Rifle Coffee Company $BRCC I should have invested in Dutch Bros $BROS and will be keeping an eye on a good entry point with them since I missed the boat on their IPO launch. #Coffee and #Lambos - I'm liking this combo!

🔹Stardog Loungewear

Made from 100% hemp, this clothing is really great! Shoes, pants, tops, robes, tanks, joggers, hoodies. Very cool style, comfortable clothes. And it's loved around the Globe. Seen in GQ, Playboy $PLBY , CNN, and Forbes. I plan on ordering the sneakers lol...did I mention I'm in ♥️ with comfy fashion?

🔹Vessel. Consumer technology and accessories sector.

The craftmanship in their offerings is amazing. Attention to detail, personal, simple designs that are unforgettable.

They also show Gratitude towards military members, #veterans and their families. Vessel offers an always 20% military discount off the entire purchase for active duty, retirees, veterans, military spouses, military family members.

🔹Mind Naturals is Flora Growth's skincare line.

They believe in nurturing the mind 🧠 and body.

Cleansers, moisturizers, serums, eye cream, masks, mists, and gifts.

🔹Mambe - the food and beverage sector

Using natural and sustainable methods from responsibly sourced exotic Amazonian fruits. The brand supports agro-industrial projects and positively influences remote communities of Colombia.

If you read through the press releases at you will see so much happening with this cannabis business.

➡️They have partnered with $WMT for product distribution in Mexico, they are shipping high quality THC flower to Israel, doing export now to Spain.

2 analysts (MKM Partners and Roth Capital PA) have initiated coverage on the stock and both have rated it a strong buy. The low, average, and high price target? $11.50. Currently trading at $2.30.

2022 is the year that Flora is set to go from Loss to Profit ✅. The company has managed its capital judiciously, with debt making up 0.4% of equity. This means it has predominantly funded its operations from equity capital, and its low debt obligation reduces the risk around investing.

Now, if the US lifts prohibition and makes cannabis use recreational in the United States, can you imagine the growth this company could go through? I can. It's even in the name 😜


#cannabis #coffee #clothing #hemp #medical #medicaladvances

#bigdippers #possibilities #growth #beauty

Own your future.
Build your portfolio.

All of your investing.
All in one place.

Invest in stocks, treasuries, ETFs, crypto, and alternative assets on Public. Transfer your account to Public and get up to $10,000.
Sign Up
Contact Us
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2023 Public Holdings, Inc. All Rights Reserved.

Market data powered by Xignite.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns. You should consult your legal, tax, or financial advisors before making any financial decisions. This material is not intended as a recommendation, offer, or solicitation to purchase or sell securities, open a brokerage account, or engage in any investment strategy.

Product offerings and availability vary based on jurisdiction.

Stocks and ETFs.
Brokerage services for US-listed, registered securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Open to Public Investing is a wholly-owned subsidiary of Public Holdings, Inc. (“Public Holdings”). This is not an offer, solicitation of an offer, or advice to buy or sell securities or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured. Apex Clearing Corporation, our clearing firm, has additional insurance coverage in excess of the regular SIPC limits. Additional information can be found here.

Alternative Assets.
Brokerage services for alternative assets available on Public are offered by Dalmore Group, LLC (“Dalmore”), member of FINRA & SIPC. “Alternative assets,” as the term is used at Public, are equity securities that have been issued pursuant to Regulation A of the Securities Act of 1933 (as amended) (“Regulation A”). This content is not investment advice. These investments are speculative, involve substantial risks (including illiquidity and loss of principal), and are not FDIC or SIPC insured. Alternative Assets purchased on the Public platform are not held in an Open to the Public Investing brokerage account and are self-custodied by the purchaser. The issuers of these securities may be an affiliate of Public, and Public (or an affiliate) may earn fees when you purchase or sell Alternative Assets. For more information on risks and conflicts of interest, see these disclosures. An affiliate of Public may be “testing the waters” and considering making an offering of securities under Tier 2 of Regulation A. No money or other consideration is being solicited and, if sent in response, will not be accepted. No offer to buy securities can be accepted, and no part of the purchase price can be received, until an offering statement filed with the SEC has been qualified by the SEC. Any such offer may be withdrawn or revoked, without obligation or commitment of any kind, at any time before notice of acceptance given after the date of qualification by the SEC or as stated in the offering materials relating to an investment opportunity, as applicable. An indication of interest to purchase securities involves no obligation or commitment of any kind.

Cryptocurrency execution and custody services are provided by Bakkt Crypto Solutions LLC (NMLS ID 1828849) through a software licensing agreement between Bakkt Crypto Solutions LLC and Public Platform LLC. Bakkt Crypto is not a registered broker-dealer or a member of SIPC or FINRA. Cryptocurrencies are not securities and are not FDIC or SIPC insured. Bakkt Crypto is licensed to engage in virtual currency business activity by the New York State Department of Financial Services. Please ensure that you fully understand the risks involved before trading: Bakkt Crypto Disclosures.

U.S. Treasuries (“T-Bill“) investing services on the Public Platform are offered by Jiko Securities, Inc. (“JSI”), a registered broker-dealer and member of FINRA & SIPC. See JSI’s FINRA BrokerCheck and Form CRS for further information. When you enable T-Bill investing on the Public platform, you open a separate brokerage account with JSI (the “Treasury Account“).

JSI uses funds from your Treasury Account to purchase T-bills in increments of $100 “par value” (the T-bill’s value at maturity). T-bills are purchased at a discount to the par value and the T-bill’s yield represents the difference in price between the “par value” and the “discount price.” Aggregate funds in your Treasury Account in excess of the T-bill purchases will remain in your Treasury Account as cash. The value of T-bills fluctuate and investors may receive more or less than their original investments if sold prior to maturity. T-bills are subject to price change and availability - yield is subject to change. Past performance is not indicative of future performance. Investments in T-bills involve a variety of risks, including credit risk, interest rate risk, and liquidity risk. As a general rule, the price of a T-bills moves inversely to changes in interest rates. See Jiko U.S. Treasuries Risk Disclosures for further details.

Investments in T-bills: Not FDIC Insured; No Bank Guarantee; May Lose Value.

Banking services and bank accounts are offered by Jiko Bank, a division of Mid-Central National Bank, Member FDIC.

JSI and Jiko Bank are not affiliated with Public Holdings, Inc. (“Public”) or any of its subsidiaries. None of these entities provide legal, tax, or accounting advice. You should consult your legal, tax, or financial advisors before making any financial decisions. This material is not intended as a recommendation, offer, or solicitation to purchase or sell securities, open a brokerage account, or engage in any investment strategy.

Commission-free trading of stocks and ETFs refers to $0 commissions for Open to the Public Investing self-directed individual cash brokerage accounts that trade the U.S.-listed, registered securities electronically during the Regular Trading Hours. Keep in mind that other fees such as regulatory fees, Premium subscription fees, commissions on trades during extended trading hours, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more.

Fractional shares are illiquid outside of Public and not transferable. For a complete explanation of conditions, restrictions and limitations associated with fractional shares, see our Fractional Share Disclosure to learn more.